Clinical Trial Update: Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CVHNLC in combination with pembrolizumab for squamous non-small cell lung cancer, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• CVHNLC
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: CureVac | Conditions: Squamous NSCLC | Phase 1 | Status: NOT_YET_RECRUITING